Personalis Inc Market Cap ($1.68 Billion)
Market Cap & Net Worth: Personalis Inc (PSNL)
Personalis Inc market cap. Personalis Inc (NASDAQ:PSNL) has a market capitalization of $1.68 Billion ($1.68 Billion) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6513 globally and #2073 in its home market, demonstrating a -0.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Personalis Inc's stock price $15.75 by its total outstanding shares 106799872 (106.80 Million). Also see Personalis Inc (PSNL) cash conversion ratio for how efficiently the company converts equity into cash flow.
Personalis Inc Market Cap History (2019–2026)
Personalis Inc market cap history from 2019 to 2026. Data shows change from $1.16 Billion to $1.68 Billion (-7.72% CAGR). Check PSNL share price today for real-time trading data and today's change.
Index Memberships
Personalis Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.06% | #187 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #734 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.83 Trillion | 0.09% | #111 of 263 |
Weight: Personalis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Personalis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Personalis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Personalis Inc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
12.21x
Personalis Inc's market cap is 12.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.16 Billion | $65.21 Million | -$25.08 Million | 17.85x | N/A |
| 2020 | $3.91 Billion | $78.65 Million | -$41.28 Million | 49.71x | N/A |
| 2021 | $1.52 Billion | $85.49 Million | -$65.23 Million | 17.83x | N/A |
| 2022 | $211.46 Million | $65.05 Million | -$113.31 Million | 3.25x | N/A |
| 2023 | $224.28 Million | $73.48 Million | -$108.30 Million | 3.05x | N/A |
| 2024 | $617.30 Million | $84.61 Million | -$81.28 Million | 7.30x | N/A |
| 2025 | $850.13 Million | $69.65 Million | -$81.27 Million | 12.21x | N/A |
Competitor Companies of PSNL by Market Capitalization
Companies near Personalis Inc in the global market cap rankings as of November 4, 2026. Also see how large is Personalis Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Personalis Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of Personalis Inc (2019–2026)
Market capitalization of Personalis Inc from 2019 to today. Between 2019 and today, Personalis Inc's market cap moved from $1.16 Billion to $ 1.68 Billion, with a yearly change of -7.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.68 Billion | +97.86% |
| 2025 | $850.13 Million | +37.72% |
| 2024 | $617.30 Million | +175.24% |
| 2023 | $224.28 Million | +6.06% |
| 2022 | $211.46 Million | -86.12% |
| 2021 | $1.52 Billion | -61.02% |
| 2020 | $3.91 Billion | +235.87% |
| 2019 | $1.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Personalis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.68 Billion USD |
| MoneyControl | $1.68 Billion USD |
| MarketWatch | $1.68 Billion USD |
| marketcap.company | $1.68 Billion USD |
| Reuters | $1.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Personalis Inc
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole tran… Read more